Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Adrenal Insufficiency × Prednisone × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 196 Lymphoma, Large B-Cell, Diffuse 147 Lymphoma 141 Precursor Cell Lymphoblastic Leukemia-Lymphoma 72 Lymphoma, Follicular 68 Lymphoma, Non-Hodgkin 61 Burkitt Lymphoma 59 Multiple Myeloma 53 Leukemia 48 Hodgkin Disease 40 Lymphoma, Mantle-Cell 32 Neoplasms 29 Lymphoma, B-Cell 25 Lymphoma, Large-Cell, Immunoblastic 23 Lymphoma, B-Cell, Marginal Zone 23 Neoplasm Metastasis 22 Lymphoma, T-Cell, Peripheral 22 Neoplasms, Plasma Cell 20 Lymphoma, Large-Cell, Anaplastic 20 Leukemia, Lymphocytic, Chronic, B-Cell 20 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 18 Recurrence 14 Dendritic Cell Sarcoma, Interdigitating 14 Immunoblastic Lymphadenopathy 12 Lymphoma, T-Cell 9 Waldenstrom Macroglobulinemia 8 Myelodysplastic Syndromes 8 Leukemia, Biphenotypic, Acute 8 Blast Crisis 8 Prostate Cancer Metastatic 7

Interventions

ravulizumab 1 Saline Solution 1 Prednisone 1 Prednisolone 1 Hydrocortisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07221838 2026-03-03

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Not yet recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡